ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA–MONO) and rucaparib in combination with nivolumab (ATHENA–COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer
Titel:
ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA–MONO) and rucaparib in combination with nivolumab (ATHENA–COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer
Auteur:
Monk, Bradley J Coleman, Robert L Fujiwara, Keiichi Wilson, Michelle K Oza, Amit M Oaknin, Ana O’Malley, David M Lorusso, Domenica Westin, Shannon N Safra, Tamar Herzog, Thomas J Marmé, Frederik N Eskander, Ramez Lin, Kevin K Shih, Danny Goble, Sandra Grechko, Nikolay Hume, Stephanie Maloney, Lara McNeish, Iain A Kristeleit, Rebecca S
Verschenen in:
International journal of gynecological cancer
Paginering:
Jaargang 31 () nr. 12 pagina's p.
Jaar:
2021
Inhoud:
Uitgever:
IGCS and ESGO 2021. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ.